Alzheimer’s Researchers Probe New Treatment Paths

The commercial failure of Biogen Inc.’s Aduhelm Drugs. is focusing on studying the causes of Alzheimer’s disease.

According to the Alzheimer’s Association, an advocacy group, more than six million people in the US are living with advanced dementia. Alzheimer’s Researchers Probe New Treatment Paths

Edmund DeMarche is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – The content will be deleted within 24 hours.

Related Articles

Back to top button